Matches in SemOpenAlex for { <https://semopenalex.org/work/W1929100524> ?p ?o ?g. }
- W1929100524 abstract "Drug resistance remains a major obstacle to malaria treatment and control. It can arise and spread rapidly, and vary substantially even at sub-national level. National malaria programmes require cost-effective and timely ways of characterizing drug-resistance at multiple sites within their countries.An improved multiplexed post-PCR ligase detection reaction-fluorescent microsphere assay (LDR-FMA) was used to simultaneously determine the presence of mutations in chloroquine resistance transporter (crt), multidrug resistance 1 (mdr1), dihydrofolate reductase (dhfr) and dihydropteroate synthase (dhps) genes in Plasmodium falciparum (n = 727) and Plasmodium vivax (n = 574) isolates collected in 2006 from cross-sectional community population surveys in two geographically distinct regions (Madang and East Sepik) of Papua New Guinea (PNG) where strong regional differences in in vivo aminoquinoline and antifolate therapeutic efficacy had previously been observed. Data were compared to those of a follow-up survey conducted in 2010.Despite some very low parasite densities, the assay successfully amplified all P. falciparum and P. vivax loci in 77 and 69 % of samples, respectively. In 2006, prevalences of pfdhfr (59R-108 N) double mutation/wild type pfdhps haplotype, pfcrt SVMNT haplotype (72S-76T double mutation), and 86Y pfmdr1 mutation all exceeded 90 %. For P. vivax, 65 % carried at least two pvdhfr mutations, 97 % the 647P pvdhps mutation and 54 % the 976F pvmdr1 mutation. Prevalence of mutant haplotypes was higher in Madang than East Sepik for pfcrt SVMNT (97.4 vs 83.3 %, p = 0.001), pfdhfr (59R-108 N) (100 vs 90.6 %, p = 0.001), pvdhfr haplotypes (75.8 vs 47.6 %, p = 0.001) and pvmdr1 976F (71.2 vs 26.2 %, p < 0.001). Data from a subsequent Madang survey in 2010 showed that the prevalence of pfdhps mutations increased significantly from <5 % to >30 % (p < 0.001) as did the prevalence of pvdhfr mutant haplotypes (from 75.8 to 97.4 %, p = 0.012).This LDR-FMA multiplex platform shows feasibility for low-cost, high-throughput, rapid characterization of a broad range of drug-resistance markers in low parasitaemia infections. Significant geographical differences in mutation prevalence correlate with previous genotyping surveys and in vivo trials and may reflect variable drug pressure and differences in health-care access in these two PNG populations." @default.
- W1929100524 created "2016-06-24" @default.
- W1929100524 creator A5002806287 @default.
- W1929100524 creator A5004820565 @default.
- W1929100524 creator A5012050869 @default.
- W1929100524 creator A5013302210 @default.
- W1929100524 creator A5021460647 @default.
- W1929100524 creator A5022834497 @default.
- W1929100524 creator A5043426673 @default.
- W1929100524 creator A5043791621 @default.
- W1929100524 creator A5055793452 @default.
- W1929100524 creator A5067372054 @default.
- W1929100524 creator A5067520857 @default.
- W1929100524 creator A5071605724 @default.
- W1929100524 creator A5078585729 @default.
- W1929100524 creator A5083893071 @default.
- W1929100524 creator A5084635606 @default.
- W1929100524 creator A5089605697 @default.
- W1929100524 date "2015-10-09" @default.
- W1929100524 modified "2023-10-13" @default.
- W1929100524 title "Significant geographical differences in prevalence of mutations associated with Plasmodium falciparum and Plasmodium vivax drug resistance in two regions from Papua New Guinea" @default.
- W1929100524 cites W1968543514 @default.
- W1929100524 cites W1975267889 @default.
- W1929100524 cites W1986339906 @default.
- W1929100524 cites W1997664087 @default.
- W1929100524 cites W2004344387 @default.
- W1929100524 cites W2010506910 @default.
- W1929100524 cites W2018291324 @default.
- W1929100524 cites W2035877468 @default.
- W1929100524 cites W2037350416 @default.
- W1929100524 cites W2044610722 @default.
- W1929100524 cites W2047791802 @default.
- W1929100524 cites W2049183597 @default.
- W1929100524 cites W2054037475 @default.
- W1929100524 cites W2061083280 @default.
- W1929100524 cites W2063969257 @default.
- W1929100524 cites W2076655844 @default.
- W1929100524 cites W2077298443 @default.
- W1929100524 cites W2080942820 @default.
- W1929100524 cites W2080956225 @default.
- W1929100524 cites W2089706810 @default.
- W1929100524 cites W2103439634 @default.
- W1929100524 cites W2103942357 @default.
- W1929100524 cites W2104987179 @default.
- W1929100524 cites W2110186420 @default.
- W1929100524 cites W2112893129 @default.
- W1929100524 cites W2114478498 @default.
- W1929100524 cites W2116949436 @default.
- W1929100524 cites W2118415151 @default.
- W1929100524 cites W2119240836 @default.
- W1929100524 cites W2121532880 @default.
- W1929100524 cites W2124312641 @default.
- W1929100524 cites W2124634096 @default.
- W1929100524 cites W2130361510 @default.
- W1929100524 cites W2130961175 @default.
- W1929100524 cites W2131095198 @default.
- W1929100524 cites W2133901317 @default.
- W1929100524 cites W2136376571 @default.
- W1929100524 cites W2136444740 @default.
- W1929100524 cites W2138392702 @default.
- W1929100524 cites W2138588424 @default.
- W1929100524 cites W2147418461 @default.
- W1929100524 cites W2157571159 @default.
- W1929100524 cites W2157762804 @default.
- W1929100524 cites W2159686777 @default.
- W1929100524 cites W2164272027 @default.
- W1929100524 cites W2171102256 @default.
- W1929100524 cites W2407692244 @default.
- W1929100524 doi "https://doi.org/10.1186/s12936-015-0879-9" @default.
- W1929100524 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4600278" @default.
- W1929100524 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26452541" @default.
- W1929100524 hasPublicationYear "2015" @default.
- W1929100524 type Work @default.
- W1929100524 sameAs 1929100524 @default.
- W1929100524 citedByCount "17" @default.
- W1929100524 countsByYear W19291005242016 @default.
- W1929100524 countsByYear W19291005242017 @default.
- W1929100524 countsByYear W19291005242018 @default.
- W1929100524 countsByYear W19291005242019 @default.
- W1929100524 countsByYear W19291005242020 @default.
- W1929100524 countsByYear W19291005242021 @default.
- W1929100524 countsByYear W19291005242022 @default.
- W1929100524 crossrefType "journal-article" @default.
- W1929100524 hasAuthorship W1929100524A5002806287 @default.
- W1929100524 hasAuthorship W1929100524A5004820565 @default.
- W1929100524 hasAuthorship W1929100524A5012050869 @default.
- W1929100524 hasAuthorship W1929100524A5013302210 @default.
- W1929100524 hasAuthorship W1929100524A5021460647 @default.
- W1929100524 hasAuthorship W1929100524A5022834497 @default.
- W1929100524 hasAuthorship W1929100524A5043426673 @default.
- W1929100524 hasAuthorship W1929100524A5043791621 @default.
- W1929100524 hasAuthorship W1929100524A5055793452 @default.
- W1929100524 hasAuthorship W1929100524A5067372054 @default.
- W1929100524 hasAuthorship W1929100524A5067520857 @default.
- W1929100524 hasAuthorship W1929100524A5071605724 @default.
- W1929100524 hasAuthorship W1929100524A5078585729 @default.
- W1929100524 hasAuthorship W1929100524A5083893071 @default.
- W1929100524 hasAuthorship W1929100524A5084635606 @default.
- W1929100524 hasAuthorship W1929100524A5089605697 @default.
- W1929100524 hasBestOaLocation W19291005241 @default.